Seda Pharmaceutical Development Services are leaders in Model-Informed Drug Development (MIDD), integrating ADME science with formulation, clinical strategy, and regulatory planning. Their expertise spans PBPK modeling, population PK/PD, and exposure-response analysis, enabling data-driven decision making across development stages. Seda’s multidisciplinary approach bridges preclinical and clinical domains, optimizing molecule selection, dose design, and product performance. By embedding modeling into pharmaceutical development, Seda enhances translational efficiency and de-risks complex programs for global pharma and biotech clients.

Pharmacokinetic Modelling | Seda